ADVM Insider Trading Activity and SEC Form 4 Filings
ADVM insider trading summary
Over the past 12 months, insiders at Adverum Biotechnologies, Inc. (ADVM) reported 4 sales worth $4.6M by 1 insider and 3 open-market purchases worth $765K by 2 insiders on SEC Form 4. Net insider selling was $3.8M.
Latest ADVM insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Dec 8, 2025 | Laurent Fischer | CEO, President and Director | Buy | $507K (117,614 @ $4.31) |
| Dec 5, 2025 | Peter Soparkar | Chief Operating Officer | Buy | $211K (50,000 @ $4.22) |
| Dec 5, 2025 | Laurent Fischer | CEO, President and Director | Buy | $47K (11,085 @ $4.24) |
| Dec 4, 2025 | Braden Michael Leonard | Insider | Sell | $2.2M (524,560 @ $4.19) |
| Dec 3, 2025 | Braden Michael Leonard | Insider | Sell | $930K (222,925 @ $4.17) |
| Dec 2, 2025 | Braden Michael Leonard | Insider | Sell | $218K (51,961 @ $4.20) |
| Dec 1, 2025 | Braden Michael Leonard | Insider | Sell | $1.3M (300,000 @ $4.20) |
| May 15, 2025 | Laurent Fischer | CEO, President and Director | Sell | $18K (9,126 @ $2.00) |
| May 15, 2025 | Peter Soparkar | Chief Operating Officer | Sell | $6K (2,960 @ $2.00) |
| May 15, 2025 | Setareh Seyedkazemi | Chief Development Officer | Sell | $2K (924 @ $2.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.